Register for our 75-minute webinar on May 7 at 2 p.m., to analyze the U.S. Supreme Court’s recent decision in Cunningham v. Cornell University and its potential to significantly increase litigation risk for retirement and health plan sponsors.

Senate HELP Committee Chair Bill Cassidy (R-LA) recently issued a report recommending reform of the 340B drug pricing program, echoing a similar call from the Council in a report released earlier this year.

The Council hosted a webinar on April 29 at 3 p.m. to provide an update on the latest legislative, regulatory and judicial developments related to employee benefits policy in Washington, D.C.

Senator Bill Cassidy (R-LA) has offered a set of proposals for improving gig workers’ health and financial security, incorporating retirement policy recommendations advanced by the Council.

Cassidy's report is consistent with the Council's recent study showing how the drug pricing program is driving up health care costs for employers, working families and taxpayers.

In this edition of Just a Minute!, Council Senior Vice President, Global Retirement and Compensation Policy, Lynn Dudley, describes the Council's ongoing response to the Supreme Court's unfortunate ruling in an important ERISA case.

In a victory for employer plan sponsors, a federal court ruled that a Tennessee law regulating PBMs is preempted by ERISA.

As part of a growing congressional effort to address plan litigation and regulatory overreach, Republicans in the U.S. House of Representatives have introduced two bills to promote transparency and uphold the voluntary nature of the private retirement system.

In a unanimous opinion issued April 17 in Cunningham v. Cornell University, the U.S. Supreme Court held that plaintiffs alleging a prohibited transaction under ERISA can proceed to discovery by merely stating that a plan hired a service provider, without first having to show that a statutory exemption does not apply.

In an April 15 executive order, the Trump White House put forth its plan for lowering prescription drug costs. The EO does not implement specific policy initiatives or requirements at this time, but directs federal officials to make recommendations and propose regulations that address prescription drug costs.

The Arkansas legislature recently passed HB 1150, which would ban PBM-affiliated pharmacies from operating in the state starting January 1, 2026. Citing the potential harm to employers and employees, the Council urged Governor Sanders to veto the bill.

The Arkansas legislature recently passed HB 1150, which would ban PBM-affiliated pharmacies from operating in the state starting January 1, 2026. Citing the potential harm to employers and employees, the Council urged Governor Sanders to veto the bill.